Keyphrases
CBM2
100%
Multiscale Systems
100%
Cell-free DNA (cfDNA)
66%
Circulating Markers
66%
Ligase Detection Reaction
66%
Solid Phase
66%
Resource Center
66%
Biotechnology
66%
Molecular Diagnostics
66%
Clinically Significant
44%
Cell-to-cell
44%
Exosomes
44%
Whole Blood
44%
Clinical Practice
44%
Infectious Stroke
33%
Blood Draw
33%
Sequence Variation
33%
Plethora
33%
Service Project
33%
Fully Automated
33%
Enrichment Factor
33%
Blood Markers
33%
Technology Training
33%
Whole Process
33%
Electrophoretic Mobility
33%
Mixed Population
33%
Protein-free
33%
In Vitro Diagnostics
33%
Disease-specific
33%
Pertinent Information
33%
Innovative System
33%
Multiple Length Scales
33%
Technology Dissemination
33%
DNA Molecule
33%
Multidisciplinary Team
22%
Biological Cells
22%
Cell-free
22%
Infectious Diseases
22%
RNA Molecules
22%
Collaborative Projects
22%
Minimally Invasive
22%
Disease-associated
22%
Reaction Products
22%
Structural Variation
22%
Information Processing Capability
22%
Advanced Biotechnology
22%
Blood-borne
22%
Single Molecule
22%
Molecular Signature
22%
Liquid Biopsy Marker
16%
Amplification-free
11%
Isolated Tumor Cells
11%
Associated Liquids
11%
Translational Development
5%
Project Portfolio
5%
Process Automation
5%
Fluid Network
5%
Production pipeline
5%
Process Liquid
5%
Molecular Entity
5%
Time-of-flight Sensor
5%
Specific Modules
5%
Medicine and Dentistry
Flight
100%
Cell-Free DNA
100%
Molecular Diagnostics
100%
Ligase
100%
Disease
66%
Exosome
66%
Blood Disorder
50%
Cell Marker
50%
Diagnosis
33%
Infection
33%
Protein
33%
Liquid Biopsy
33%
Apoplexy
33%
In Vitro
33%
Malignant Neoplasm
33%
Nursing and Health Professions
Shoulder Prosthesis
100%
Molecular Diagnostics
100%
Ligase
66%
Clinical Practice
66%
Disease
66%
Electrophoretic Mobility
33%
Cell Marker
33%
Infection
22%
Malignant Neoplasm
22%
Diagnosis
22%